Daxor Corp 最大收入來源為 Investment and Related Activities,在最近的收益報告中收入為 -135,668。就地區而言,United States 是 Daxor Corp 的主要市場,收入為 -135,668。
Daxor Corp 是否盈利?
是的,根據最新的財務報表,Daxor Corp 的淨利潤為 $9
Daxor Corp 有負債嗎?
無,Daxor Corp 的負債為 0
Daxor Corp 的流通股有多少?
Daxor Corp 的總流通股為 5.05
關鍵數據
前收市價
$10.23
開盤價
$10.36
當日範圍
$10.29 - $10.47
52週區間
$7.1 - $14.76
交易量
6.7K
平均成交量
8.6K
股息收益率
--
每股盈餘 (TTM)
1.98
市值
$60.5M
什麼是 DXR?
Daxor Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a diversified, closed-end management investment company. Its focus and operations are as a medical device manufacturing, company. The company specializes in blood volume measurement technology focused on blood volume testing innovation. The company markets the Blood Volume Analyzer (BVA)-100, the diagnostic blood test cleared by the FDA to provide objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000 tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a range of surgical and medical conditions, including reducing mortality and readmissions in heart failure and critical care. Its facility provides on-demand, next day blood volume analysis results. The company has several ongoing trials in the areas of heart failure treatment with support from the NIH and is under contract developing analyzers to improve combat casualty care with the United States Department of Defense.